Clinical Trials Browser

Phase 2 × balstilimab × Genitourinary × Clear all

NCT05928806 2026-02-11

ARCITECT

Phase 2 Suspended

Advanced Renal Cell Carcinoma

NCT04430036 2024-04-04

AGEN1884 Plus AGEN2034 Combined With Cisplatin-Gemcitabine for Muscle-Invasive Bladder Cancer

Phase 2 Terminated

4 enrolled 9 charts

Urinary Bladder Neoplasms